Jinlong Li

839 citations
12 papers · 641 indexed · 1 hit paper · h-index 10
Topics
Cancer Cells and Metastasis (2 papers)Fibromyalgia and Chronic Fatigue Syndrome Research (1 paper)Extracellular vesicles in disease (1 paper)
Partner nations
China

In The Last Decade

Jinlong Li

10 papers receiving 638 citations

Hit Papers

Theranostic combinatorial drug-loaded coated cubosomes fo...20202026202220242020100200300

Peers

Jinlong Li
Comparison fields: 5 of 97
  • Molecular Biology 356
  • Cancer Research 199
  • Oncology 99
  • Epidemiology 58
  • Immunology 50
Replace Miao Tian with:
Miao Tian China
Zhiyu Wang China
Carmen Crivii Romania
Paola Bianciardi Italy
Naser Mobarra Iran
Solmaz Khalighfard Iran
Xiao Ding China
Weicheng Yao China
Jinlong Li relative to Miao Tian China Miao Tian's profile →
Citations per field
00.5×1.5×
Miao Tian · 1×
Citations per year

Countries citing papers authored by Jinlong Li

Since Specialization
Citations

This map shows the geographic impact of Jinlong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinlong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinlong Li more than expected).

Fields of papers citing papers by Jinlong Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinlong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinlong Li. The network helps show where Jinlong Li may publish in the future.

Co-authorship network of co-authors of Jinlong Li

This figure shows the co-authorship network connecting the top 25 collaborators of Jinlong Li. A scholar is included among the top collaborators of Jinlong Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinlong Li. Jinlong Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1 0
2 0
3 25
4 15
5 32
6 99
7
Theranostic combinatorial drug-loaded coated cubosomes for enhanced targeting and efficacy against cancer cellsbreakdown →
331
8 37
9 57
10 26
11 9
12 10

About Jinlong Li

Jinlong Li is a scholar working on Developmental Neuroscience, Pharmacy and Critical Care and Intensive Care Medicine, having authored 12 papers that have together received 641 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (2 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (1 paper) and Extracellular vesicles in disease (1 paper). The work is most often cited by research in Cancer Research (199 citations), Molecular Biology (356 citations) and Developmental Neuroscience (19 citations). Jinlong Li has collaborated with scholars based in China. Frequent co-authors include Dan Tian, Miao Tian, Leilei Zhang, Xu Wang, Lihua Sun, Lihua Sun, Gang Han, Zhiming Ma, Lili Zhang and Leilei Guo. Their work appears in journals such as PLoS ONE, Scientific Reports and Experimental Brain Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026